Welcome to our dedicated page for Kaival Brnds Innovatns Grp SEC filings (Ticker: KAVL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kaival Brands Innovations Group, Inc. (KAVL) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. These filings offer detailed insight into Kaival Brands’ ENDS distribution activities, intellectual property strategy, corporate governance, and Nasdaq listing status.
Investors can use this page to review current and periodic reports, including Forms 10‑K and 10‑Q referenced in company communications, which discuss revenues from the distribution of Bidi Vapor products, cost structures, operating expenses and risk factors tied to FDA regulation of electronic nicotine delivery systems. Proxy statements such as the Definitive Proxy Statement on Schedule 14A describe board composition, director elections, executive compensation and matters submitted to shareholder votes at annual meetings.
Frequent Form 8‑K filings document material events. Recent examples disclosed by the company include the announcement and implementation of a 1‑for‑21 reverse stock split, notices from Nasdaq regarding minimum bid price compliance and staff views on whether Kaival Brands qualifies as a “public shell,” extensions to regain listing compliance, and the mutual termination of a previously announced business combination with Delta Corp Holdings Limited. These 8‑K reports help investors follow significant corporate actions and listing‑related developments.
Filings also cover governance and audit matters, such as shareholder approval of director slates and ratification of the independent registered public accounting firm, as reported in annual meeting results. Where applicable, registration statements referenced in company news (for offerings of units or proposed business combinations) provide additional detail on securities issuance and transaction structures.
On Stock Titan, Kaival Brands filings are updated in near real time from EDGAR, and AI‑powered summaries are provided to explain the key points of lengthy documents like 10‑K annual reports, 10‑Q quarterly reports and 8‑K current reports. This allows users to quickly identify disclosures on topics such as ENDS regulatory risk, intellectual property assets at Kaival Labs, capital raising transactions and Nasdaq compliance, while retaining the ability to review the full original filings when deeper analysis is needed.
Kaival Brands Innovations Group, Inc. CFO Eric Morris reported new equity compensation awards. He received a restricted stock award covering 3,000,000 shares of common stock, with 600,000 shares vesting immediately and 2,400,000 vesting in 200,000-share quarterly installments over the next 12 fiscal quarters, subject to continued service.
He was also granted a non-qualified stock option for 3,000,000 shares of common stock at an exercise price of $0.0152 per share, expiring on March 31, 2036. Of these options, 600,000 vested immediately and 2,400,000 will vest in equal 200,000-option quarterly installments over 12 fiscal quarters, subject to continued service. Following the award, he directly holds 3,006,020 shares of common stock and 3,000,000 stock options.
Kaival Brands Innovations Group CEO Eric Mosser received significant equity compensation grants. He was awarded a restricted stock award for 3,000,000 shares of common stock, with 600,000 shares vesting immediately and 2,400,000 vesting in 200,000-share installments each fiscal quarter over the next 12 quarters, subject to continued service.
He also received a non-qualified stock option to purchase 3,000,000 shares at an exercise price of $0.0152 per share, with 600,000 options vesting immediately and the remaining 2,400,000 vesting in equal quarterly installments over the next 12 quarters. In addition, he was granted a non-qualified stock option for 586,060 shares at $0.0152 per share, with 25% vesting immediately and 75% vesting in quarterly installments over the next three fiscal quarters, all under the Amended and Restated 2020 Stock and Incentive Compensation Plan.
Kaival Brands Innovations Group director Mark L. Thoenes received a grant of stock options as equity compensation. He was awarded options to buy 500,000 shares of common stock at an exercise price of $0.0152 per share, expiring on March 31, 2036.
The options were granted under the company’s Amended and Restated 2020 Stock and Incentive Compensation Plan. They vest in four equal quarterly installments of 125,000 options at the end of each fiscal quarter over the next four quarters, subject to his continued service with the company.
Kaival Brands Innovations Group, Inc. updated its leadership compensation structure by approving new employment agreements for its Chief Executive Officer and Chief Financial Officer on March 31, 2026. The agreements emphasize equity-based pay tied to recovery milestones to support the company’s post-Nasdaq delisting recovery plan while preserving cash.
The Board, acting under DGCL §144, relied on a fairness opinion from its sole disinterested director, who concluded the arrangements are fair and reasonable to the company and its stockholders from a financial point of view. The Board also amended the Amended and Restated 2020 Stock and Incentive Compensation Plan to increase the maximum aggregate shares available under the plan to 100,000,000 shares, further aligning executive incentives with long-term stockholder value.
Kaival Brands Innovations Group, Inc. reported a net loss of $620,787 for the quarter ended January 31, 2026, compared with a loss of $4,061,080 a year earlier. Quarterly revenue was $92,938, down from $202,603, and now comes entirely from royalty income under its Philip Morris international licensing agreement.
Cash increased to $797,500 and working capital to $497,068, helped by $1,015,443 of common share issuance, but operations used $752,349 of cash. The company has ceased Bidi Stick distribution in the U.S. following FDA marketing denial orders and an ITC patent case, and explicitly warns of substantial doubt about its ability to continue as a going concern without additional capital.
Kaival Brands Innovations Group reported major governance changes as it adjusts to trading on the OTC market after its Nasdaq delisting. The board accepted the resignations of directors David Worner, Ketankumar Patel, and Ashesh Modi, effective January 31, 2026, citing cost-saving and governance streamlining, with no disagreements on company matters. Interim CEO Mark Thoenes also resigned effective February 5, 2026. The board appointed Eric Mosser as Chief Executive Officer, highlighting his prior role leading transactions such as an international licensing deal with Philip Morris International and overseeing operations that generated nearly $120 million in revenue within 12 months. Using unanimous written consent, the board also approved amended and restated bylaws and a certificate of amendment, effective February 5, 2026, to enhance governance efficiency and support the company’s recovery plan, actions that did not require stockholder approval.
Kaival Brands Innovations Group files its annual report for the year ended October 31, 2025, describing a business under significant regulatory and financial pressure. The company no longer imports or sells Bidi Sticks in the United States after an International Trade Commission patent case and a consent order stopping importation and distribution until a patent expires in October 2026. Its current primary revenue comes from an international licensing agreement with Philip Morris Products S.A. covering disposable nicotine e‑cigarette products sold in selected overseas markets. Kaival discloses a present need for additional funding, only about $0.5 million of cash and cash equivalents as of October 31, 2025, and “substantial doubt” about its ability to continue as a going concern. The report also highlights FDA marketing denial orders for both Classic and non‑tobacco flavored BIDI Sticks, heavy historical reliance on affiliate Bidi Vapor, efforts to diversify through GoFire vaporization intellectual property, and a terminated merger with Delta Corp Holdings.
Kaival Brands Innovations Group, Inc. reported that it received a notice from Nasdaq staff on November 10, 2025 stating the staff’s belief that the company is a “public shell” and that continued listing of its securities is not warranted. Nasdaq staff cited the company’s lack of revenue-generating assets, a substantial reduction in employees and operations since the fiscal year ended October 31, 2023, and that 87.7% of its assets are patents and technology without definitive commercialization plans. The notice also referenced revenue of under $400,000 for the nine months ended July 31, 2025, compared with $6.1 million for the same period in 2024. Kaival Brands disagrees with Nasdaq’s view, considers itself an operating company, and plans to timely appeal, which will stay any suspension or delisting action during the hearings process, though there is no assurance the appeal will succeed.
Kaival Brands Innovations Group, Inc. (KAVL) reported results of its 2025 annual stockholders meeting. As of the October 3, 2025 record date, 11,593,402 common shares were outstanding. A quorum was reached with 7,576,844 shares represented, equal to 65.35% of outstanding voting shares.
All director nominees were elected to serve until the 2026 annual meeting or until their successors are elected and qualified. Reported votes included: David Worner (5,515,833 for), Mark Thoenes (5,566,366 for), Ashesh Modi (5,538,862 for), and Ketankumar Patel (5,535,589 for). Directors are elected by a plurality of votes cast.
One proposal requiring a majority of outstanding shares was approved with 7,554,497 votes for, 22,094 against, and 253 abstentions.